All Stories

  1. Plasmalogens as biomarkers and therapeutic targets

    Article • Journal of Lipid Research, December 2025, Elsevier

    Colleen Curran

  2. Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model

    Article • Frontiers in Immunology, January 2024, Frontiers

    Colleen Curran

  3. The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease

    Article • Journal of Translational Medicine, October 2023, Springer Science + Business Media

    Colleen Curran

  4. Nicotinamide Antagonizes Lipopolysaccharide-Induced Hypoxic Cell Signals in Human Macrophages

    Article • The Journal of Immunology, June 2023, The American Association of Immunologists

    Colleen Curran

  5. RAGE pathway activation and function in chronic kidney disease and COVID-19

    Article • Frontiers in Medicine, August 2022, Frontiers

    Colleen Curran

  6. Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease

    Article • Frontiers in Pharmacology, February 2022, Frontiers

    Colleen Curran

  7. Anti–PD-L1 Therapy Does Not Improve Survival in a Murine Model of Lethal Staphylococcus aureus Pneumonia

    Article • The Journal of Infectious Diseases, May 2021, Oxford University Press (OUP)

    Colleen Curran

  8. PD-1 immunobiology in glomerulonephritis and renal cell carcinoma

    Article • BMC Nephrology, March 2021, Springer Science + Business Media

    Colleen Curran

  9. Observation and Quantification of Eosinophil Motility

    Article • January 2021, Springer Science + Business Media

    Colleen Curran

  10. COVID-19 Usurps Host Regulatory Networks

    Article • Frontiers in Pharmacology, August 2020, Frontiers

    Colleen Curran

  11. The Mammary Tumor Microenvironment

    Article • January 2020, Springer Science + Business Media

    Colleen Curran

  12. Report on the 2018 Cancer, Autoimmunity, and Immunology Conference

    Article • The Journal of Immunology, April 2019, The American Association of Immunologists

    Dr Howard A Young, Colleen Curran

  13. PD-1 immunobiology in systemic lupus erythematosus

    Article • Journal of Autoimmunity, November 2018, Elsevier

    Colleen Curran

  14. Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection

    Article • American Review of Respiratory Disease, March 2018, American Thoracic Society

    Colleen Curran

  15. Report on the NCI Microbial-Based Cancer Therapy Conference

    Article • Cancer Immunology Research, January 2018, American Association for Cancer Research (AACR)

    Colleen Curran

  16. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma

    Article • Seminars in Oncology, December 2017, Elsevier

    Colleen Curran

  17. Report on the FDA-AACR Immuno-oncology Drug Development Workshop

    Article • Cancer Immunology Research, April 2017, American Association for Cancer Research (AACR)

    Colleen Curran

  18. Designing a broad-spectrum integrative approach for cancer prevention and treatment

    Article • Seminars in Cancer Biology, December 2015, Elsevier

    Professor Nicol Keith, Dr. H.P. Vasantha Rupasinghe, Colleen Curran, Dr Gunjan Guha, Tetsuro Sasada, Gloria Huang

  19. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead

    Article • Carcinogenesis, June 2015, Oxford University Press (OUP)

    Dr Chiara Mondello, Dr Nicole Kleinstreuer, Dr GRAEME P WILLIAMS, Dr VALERIAN DORMOY, Professor Po Sing Leung, Colleen Curran, Laura Soucek

  20. The effect of environmental chemicals on the tumor microenvironment

    Article • Carcinogenesis, June 2015, Oxford University Press (OUP)

    Dr Chiara Mondello, Colleen Curran, Laura Soucek

  21. Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells

    Article • Environmental Toxicology and Pharmacology, January 2015, Elsevier

    Colleen Curran

  22. LPS Modulates Rhinovirus-Induced Chemokine Secretion in Monocytes and Macrophages

    Article • American Journal of Respiratory Cell and Molecular Biology, July 2014, American Thoracic Society

    Colleen Curran

  23. Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages

    Article • Journal of Allergy and Clinical Immunology, April 2014, Elsevier

    Colleen Curran

  24. Human Eosinophil Adhesion and Receptor Expression

    Article • January 2014, Springer Science + Business Media

    Colleen Curran

  25. Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition

    Article • Matrix Biology, March 2013, Elsevier

    Colleen Curran

  26. Lactoferrin Regulates an Axis Involving CD11b and CD49d Integrins and the Chemokines MIP-1α and MCP-1 in GM-CSF-Treated Human Primary Eosinophils

    Article • Journal of Interferon & Cytokine Research, October 2012, Mary Ann Liebert Inc

    Colleen Curran

  27. Eosinophils in glioblastoma biology

    Article • Journal of Neuroinflammation, January 2012, Springer Science + Business Media

    Colleen Curran

  28. Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B

    Article • International Immunology, October 2011, Oxford University Press (OUP)

    Colleen Curran

  29. GM-CSF Production by Glioblastoma Cells Has a Functional Role in Eosinophil Survival, Activation, and Growth Factor Production for Enhanced Tumor Cell Proliferation

    Article • The Journal of Immunology, August 2011, The American Association of Immunologists

    Colleen Curran

  30. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways

    Article • Cellular Immunology, July 2006, Elsevier

    Colleen Curran